Back to Search
Start Over
Solvent-Mediated Polymorphic Transformations in Molten Polymers: The Account of Acetaminophen.
- Source :
-
Molecular pharmaceutics [Mol Pharm] 2022 Jul 04; Vol. 19 (7), pp. 2183-2190. Date of Electronic Publication: 2022 Apr 27. - Publication Year :
- 2022
-
Abstract
- Solvent-mediated polymorphic transformations (SMPTs) employing nonconventional solvents (polymer melts) is an underexplored research topic that limits the application of polymer-based formulation processes. Acetaminophen (ACM), a widely studied active pharmaceutical ingredient (API), is known to present SMPTs spontaneously (<30 s) in conventional solvents such as ethanol. In situ Raman spectroscopy was employed to monitor the induction time for the SMPT of ACM II to I in polyethylene glycol (PEG) melts of different molecular weights ( M <subscript>w</subscript> , 4000, 10 000, 20 000, 35 000 g/mol). The results presented here demonstrate that the induction time for the SMPT of ACM II to I in PEG melts is driven by its diffusivity through the polymer melts. Compared to conventional solvents ( i.e. , ethanol) the mass transfer (diffusion coefficient, D ) in melts is significantly hindered ( D <subscript>ethanol</subscript> = 4.84 × 10 <superscript>-9</superscript> m <superscript>2</superscript> /s > D <subscript>PEGs</subscript> = 5.32 × 10 <superscript>-11</superscript> -8.36 × 10 <superscript>-14</superscript> m <superscript>2</superscript> /s). Ultimately, the study proves that the induction time for the SMPT can be tuned by understanding the dispersant's physicochemical properties ( i.e. , η) and, thus, the D of the solute in the dispersant. This allows one to kinetically access and stabilize metastable forms or delay their transformations under given process conditions.
Details
- Language :
- English
- ISSN :
- 1543-8392
- Volume :
- 19
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Molecular pharmaceutics
- Publication Type :
- Academic Journal
- Accession number :
- 35475360
- Full Text :
- https://doi.org/10.1021/acs.molpharmaceut.2c00035